×
About 6,373 results

ALLMedicine™ Attention Deficit Hyperactivity Disorder Center

Research & Reviews  2,217 results

The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Defici...
https://doi.org/10.2174/1570159X19666210920091036
Current Neuropharmacology; Peedicayil J

Sep 22nd, 2021 - There is increasing evidence that dsyregulated epigenetic mechanisms of gene expression are involved in the pathogenesis of attention deficit hyperactivity disorder (ADHD). This review presents a comprehensive summary of the current state of resea...

Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychom...
https://doi.org/10.1186/s12888-021-03462-1 10.1007/PL00005481 10.1176/appi.ajp.158.11.1783 10.1016/j.neubiorev.2007.11.003 10.1016/0191-8869(85)90011-X 10.1037/1064-1297.11.3.210 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 10.1016/j.paid.2009.04.008 10.1037/a0032161 10.1002/jclp.1051 10.1016/j.jad.2007.07.011 10.1016/j.jad.2006.09.037 10.1348/000712605X79111 10.1016/j.jpsychires.2009.03.003 10.1177/1087054713495737 10.1016/j.alcohol.2004.06.012 10.1016/S0306-4603(00)00062-9 10.1159/000079110 10.1159/000494697 10.1007/s00115-007-2360-7 10.2466/08.09.10.PMS.112.2.353-368 10.1016/j.ijchp.2015.07.002 10.1002/brb3.605 10.2466/pms.104.4.1169-1182 10.1590/S1516-44462006005000020 10.1016/j.encep.2012.06.034 10.1046/j.1440-1819.2001.00796.x 10.1016/j.euroneuro.2015.09.018 10.1111/acer.13910 10.1016/j.drugalcdep.2018.06.023 10.1007/978-1-4612-0357-5_3 10.1016/S0165-0327(00)00242-1 10.1017/S0033291704002892 10.1111/j.1530-0277.1995.tb01475.x 10.1034/j.1600-0447.2000.102003217.x 10.1016/S0140-6736(86)90837-8 10.32614/RJ-2014-031 10.18637/jss.v048.i02 10.18637/jss.v040.i01 10.5116/ijme.4dfb.8dfd 10.1016/j.addbeh.2005.05.009
BMC Psychiatry; Khemiri L, Brynte C et. al.

Sep 20th, 2021 - Impulsivity is associated with several psychiatric disorders, including substance use disorders (SUD) and attention deficit hyperactivity disorder (ADHD). A widely used questionnaire to assess impulsivity is the Barratt Impulsiveness Scale (BIS), ...

Drugs for patients with epilepsy and excessive daytime sleepiness.
https://doi.org/10.1016/j.yebeh.2021.108311
Epilepsy & Behavior : E&B; Zaccara G, Bartolini E et. al.

Sep 18th, 2021 - Excessive daytime sleepiness (EDS) and attentional deficits are often observed in people with epilepsy. They may be the consequence of seizures and subclinical discharges as well as of comorbid conditions as obstructive sleep apnea/hypopnea syndro...

Shorter rapid eye movement sleep duration in children with attention-deficit /hyperacti...
https://doi.org/10.1016/j.sleep.2021.07.034
Sleep Medicine; Darweesh AEM, El Beh KA et. al.

Sep 18th, 2021 - The relationship of sleep with attention deficit hyperactivity disorder (ADHD) remains complex and unclear. The current study aimed to compare the subjective and objective sleep parameters among children with and without ADHD. Moreover, to address...

Targeting working memory to modify emotional reactivity in adult attention deficit hype...
https://doi.org/10.1007/s11682-021-00532-6 10.1080/0959523031000154454 10.1016/j.appet.2012.02.044 10.1002/pchj.353 10.1001/archpsyc.1961.01710120031004 10.1186/s12888-020-2442-7 10.1159/000081413 10.1176/appi.ajp.2009.09010043 10.1176/appi.ajp.2012.11101521 10.1002/hbm.22342 10.1016/j.neuroimage.2007.05.006 10.1038/s41596-020-0327-3 10.1038/s41592-018-0235-4 10.1002/9781118856406.app5 10.1371/journal.pone.0027240 10.1177/00222194070400010401 10.1007/s00787-004-1008-4 10.1016/j.cpr.2016.04.011 10.1016/j.neubiorev.2012.11.015 10.1007/s10802-019-00612-8 10.1016/j.neulet.2016.04.037 10.1111/j.1360-0443.1991.tb01879.x 10.1007/s12402-010-0047-6 10.1038/s41598-019-42018-y 10.1002/hbm.24232 10.1016/j.cpr.2008.05.004 10.1016/j.neuroimage.2011.09.015 10.1007/s00213-017-4785-4 10.1017/S0033291711001097 10.1007/s00406-013-0407-2 10.1002/hbm.21058 10.1177/1087054707299367 10.1016/j.brainres.2012.02.027 10.1016/j.neubiorev.2017.08.010 10.1017/S0033291714002013 10.1016/j.bandc.2013.06.004 10.1017/S0033291713000469 10.1016/j.jbtep.2016.03.007 10.1111/j.2044-8260.1992.tb00997.x 10.3109/15622975.2011.599213 10.1371/journal.pone.0107750 10.1371/journal.pone.004939 10.1503/jpn.180139 10.1016/j.nicl.2015.12.003 10.1016/j.brat.2010.02.001 10.1002/jclp 10.1007/s11682-018-9925-x 10.1016/j.dcn.2017.06.004 10.1016/j.neuroscience.2005.09.018 10.1016/j.jaac.2010.07.009 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 10.1016/j.biopsych.2008.07.008 10.1016/j.pscychresns.2011.02.005 10.1016/j.jaac.2011.05.010 10.1016/j.brainres.2011.02.07 10.1176/appi.ajp.2017.1604046 10.1371/journal.pone.0055613 10.1016/j.neuroimage.2007.06.037 10.1111/j.1360-0443.1993.tb02093.x 10.1214/aos/1176344136 10.1176/appi.ajp.157.2.278 10.1016/j.biopsych.2004.07.011 10.1523/JNEUROSCI.2593-12.2013 10.1542/peds.2013-3686 10.1016/J.NEUBIOREV.2007.12.002 10.1038/nrn2994 10.1038/s41598-017-02266-2 10.1017/neu.2015.34 10.1177/1087054716629213 10.1038/s41598-018-24944-5 10.1007/s11682-020-00338-y 10.1080/02699931.2013.848785 10.1111/jcpp.12868 10.1080/15622975.2019.1585946 10.1016/j.neuroimage.2009.01.016 10.1016/j.psychres.2017.04.027 10.1016/j.jadohealth.2009.09.009 10.1037/a0031924 10.3109/15622975.2015.1112032 10.1016/J.NEUROIMAGE.2014.01.060
Brain Imaging and Behavior; Kaiser A, Reneman L et. al.

Sep 16th, 2021 - Understanding the neural mechanisms of emotional reactivity in Attention-Deficit/Hyperactivity Disorder (ADHD) may help develop more effective treatments that target emotion dysregulation. In adult ADHD, emotion regulation problems cover a range o...

see more →

Guidelines  2 results

Evidence-based guidelines for the pharmacological management of attention deficit hyper...
https://doi.org/10.1177/0269881113519509
Journal of Psychopharmacology (Oxford, England); Bolea-Alamañac B, Nutt DJ et. al.

Feb 15th, 2014 - Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. T...

Responding to requests from adult patients for neuroenhancements: guidance of the Ethic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769556
Neurology Larriviere D, Williams MA et. al.

Sep 25th, 2009 - In the last decade, persons who have no diagnosed medical or mental health condition are increasingly seeking and utilizing, for the ostensible purpose of enhancing their memory or cognitive skills, prescription drugs that were originally develope...

see more →

Drugs  212 results see all →

News  118 results

Mindfulness Benefits Kids With ADHD and Their Families
https://www.medscape.com/viewarticle/954838

Jul 15th, 2021 - Meditation, yoga, breathing exercises, and other mindfulness activities can help children with attention deficit hyperactivity disorder, but it's not just the kids who benefit. When families of children with ADHD complete a mindfulness program tog...

Dose-Dependent Effect of 'Internet Addiction' and Sleep Problems
https://www.medscape.com/viewarticle/953742

Jun 25th, 2021 - More evidence suggests the severity of internet addiction (IA) is directly related to the severity of sleep problems in youth. Results from a study of more than 4000 adolescent students show IA severity was linked to less sleep and to daytime slee...

New Obesity Target? Dopamine Circuit in Brainstem Affects Satiety
https://www.medscape.com/viewarticle/952462

Jun 4th, 2021 - Researchers have discovered a new dopaminergic neural circuit leading to the hindbrain that is involved in satiety (feeling full and eating cessation) in mice, which may eventually lead to new ways to treat obesity. Moreover, when mice were given ...

FDA Clears Nonstimulant for ADHD in Kids 6 Years and Up
https://www.medscape.com/viewarticle/948727

Apr 5th, 2021 - The US Food and Drug Administration (FDA) has approved the nonstimulant medication viloxazine extended-release capsules (Qelbree, Supernus Pharmaceuticals) for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 to ...

Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg Due to Trace Amounts of Quetiapine Fumarate | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-guanfacine-extended-release-tablets-2mg-due-trace

Summary Company Announcement Date: March 31, 2021 FDA Publish Date: March 31, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Trace amounts of Quetiapine Fumarate Company Name: Apotex Corp. Brand Name: Brand Name(s) Apo...

see more →